Carisma Therapeutics Forecast, price target & analysts
$0.02
3,900.00%
NYSE, Oct 15, 04:00 pm EDT.
Industry
Carisma Therapeutics Target price 2026 - Analyst rating & recommendation
Powered by
Carisma Therapeutics Classifications & Recommendation
Hold
50%
Sell
50%
Carisma Therapeutics Price Target
| Target Price | $1.02 |
| Price | $0.00 |
| Potential | |
| Number of Estimates | 3 |
| 3 Analysts have issued a price target Carisma Therapeutics 2027 . The average Carisma Therapeutics target price is $1.02. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 6 analysts: 0 Analysts recommend Carisma Therapeutics to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Carisma Therapeutics stock has an average upside potential 2027 of . Most analysts recommend the Carisma Therapeutics stock at Sell or hold. |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? |
4 Analysts have issued a Carisma Therapeutics forecast for earnings per share. The average Carisma Therapeutics EPS is
. This is than earnings per share in the financial year 2024. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
P/E ratio
| Current | 0.00 | 99.69% |
|---|---|---|
| 2025 | ||
Carisma Therapeutics...
Current Carisma Therapeutics Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
